Rapid Communication |
Presented in part at the 71st Scientific Sessions of the American Heart Association, Dallas, Tex, November 811, 1998.
From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
Correspondence to Ken-ichi Hirano, MD, PhD, Department of Internal Medicine and Molecular Science, Graduate School of Medicine, B5, Osaka University, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail khirano{at}kb3.so-net.ne.jp
AbstractThe scavenger receptor
class B type I (SR-BI) and its human homologue CLA-1 (CD36
and LIMPII Analogous-1) have
recently been identified to bind HDL and mediate the selective uptake
of HDL lipids. Tissue distribution of both murine and human receptors
is quite similar, in that they are expressed abundantly in liver and
steroidogenic tissues. However, expression and function of the human
SR-BI (hSR-BI), in the periphery of reverse cholesterol
transport such as macrophages, are still unclear. In the
present study, we have raised two different kinds of antihSR-BI
polypeptide antibodies (Abs): one against the extracellular domain and
the other against the intracellular domain. We have investigated
the expression of hSR-BI mRNA and immunoreactive mass in freshly
isolated cultured human monocyte-derived macrophages (hM
)
and in atherosclerotic lesions. Contrary to the earlier report, hSR-BI
mRNA was expressed in cultured hM
and markedly upregulated with
differentiation, determined by Northern blot and reverse
transcriptasebased polymerase chain reaction analyses. The
mRNA expression pattern during differentiation of hM
was very
similar to those of SR class A and another member of SR class B, CD36.
Protein expression was confirmed by Western blot analyses with
the above Abs to show a major 83-kDa band. Modified lipoproteins such
as oxidized LDL and acetylated LDL induced a 5-fold increase in
mRNA and protein expression of hSR-BI. Confocal
immunofluorescence microscopy demonstrated that
hSR-BI immunoreactive mass was detectable as a
heterogeneous, punctate staining pattern. Furthermore,
immunohistochemical analysis showed that immunoreactive mass of
hSR-BI was detected in foam cells in human aortic atherosclerotic
lesions and that there was no significant difference of staining
patterns between the two Abs. This study clearly demonstrates that
hSR-BI is expressed in the lipid-laden macrophages in human
atherosclerotic lesions, suggesting that it is very important to know
its function and regulation in hM
to understand the biological
utility of this molecule.
Key Words: atherosclerosis human scavenger receptor class B type I high-density lipoprotein reverse cholesterol transport scavenger receptor
This article has been cited by other articles:
![]() |
M. West, E. Greason, A. Kolmakova, A. Jahangiri, B. Asztalos, T. I. Pollin, and A. Rodriguez Scavenger Receptor Class B Type I Protein as an Independent Predictor of High-Density Lipoprotein Cholesterol Levels in Subjects with Hyperalphalipoproteinemia J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bulat, G. Waeber, and C. Widmann LDLs stimulate p38 MAPKs and wound healing through SR-BI independently of Ras and PI3 kinase J. Lipid Res., January 1, 2009; 50(1): 81 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Quinn, M. Henriques, T. Parker, A. S. Slutsky, and H. Zhang Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1817 - H1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Komori, H. Arai, T. Kashima, T. Huby, T. Kita, and Y. Ueda Coexpression of CLA-1 and Human PDZK1 in Murine Liver Modulates HDL Cholesterol Metabolism Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1298 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marsche, P. G. Furtmuller, C. Obinger, W. Sattler, and E. Malle Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro Cardiovasc Res, July 1, 2008; 79(1): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, B. B. Boyanovsky, M. A. Connelly, P. Shridas, D. R. van der Westhuyzen, and N. R. Webb Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI J. Lipid Res., December 1, 2007; 48(12): 2560 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marsche, B. Weigle, W. Sattler, and E. Malle Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein FASEB J, October 1, 2007; 21(12): 3075 - 3082. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koseki, K.-i. Hirano, D. Masuda, C. Ikegami, M. Tanaka, A. Ota, J. C. Sandoval, Y. Nakagawa-Toyama, S. B. Sato, T. Kobayashi, et al. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-{alpha} secretion in Abca1-deficient macrophages J. Lipid Res., February 1, 2007; 48(2): 299 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Marcil, E. Delvin, A. T. Sane, A. Tremblay, and E. Levy Oxidative stress influences cholesterol efflux in THP-1 macrophages: Role of ATP-binding cassette A1 and nuclear factors Cardiovasc Res, December 1, 2006; 72(3): 473 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brundert, J. Heeren, M. Bahar-Bayansar, A. Ewert, K. J. Moore, and F. Rinninger Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI J. Lipid Res., November 1, 2006; 47(11): 2408 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tancevski, A. Wehinger, W. Schgoer, P. Eller, S. Cuzzocrea, B. Foeger, J. R. Patsch, and A. Ritsch Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice FASEB J, July 1, 2006; 20(9): 1328 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 706 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsuyama, N. Sakai, H. Hiraoka, K.-i. Hirano, and S. Yamashita Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages J. Lipid Res., January 1, 2006; 47(1): 78 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Hirano, C. Ikegami, K.-i. Tsujii, Z. Zhang, F. Matsuura, Y. Nakagawa-Toyama, M. Koseki, D. Masuda, T. Maruyama, I. Shimomura, et al. Probucol Enhances the Expression of Human Hepatic Scavenger Receptor Class B Type I, Possibly Through a Species-Specific Mechanism Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2422 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. van der Westhuyzen, L. Cai, M. C. de Beer, and F. C. de Beer Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I J. Biol. Chem., October 28, 2005; 280(43): 35890 - 35895. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cai, M. C. de Beer, F. C. de Beer, and D. R. van der Westhuyzen Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake J. Biol. Chem., January 28, 2005; 280(4): 2954 - 2961. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van Eck, I. S. T. Bos, R. B. Hildebrand, B. T. Van Rij, and T. J.C. Van Berkel Dual Role for Scavenger Receptor Class B, Type I on Bone Marrow-Derived Cells in Atherosclerotic Lesion Development Am. J. Pathol., September 1, 2004; 165(3): 785 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, G. Cao, J. Repa, and H. Stangl Sterol regulation of scavenger receptor class B type I in macrophages J. Lipid Res., May 1, 2004; 45(5): 889 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marsche, R. Zimmermann, S. Horiuchi, N. N. Tandon, W. Sattler, and E. Malle Class B Scavenger Receptors CD36 and SR-BI Are Receptors for Hypochlorite-modified Low Density Lipoprotein J. Biol. Chem., November 28, 2003; 278(48): 47562 - 47570. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Trigatti, M. Krieger, and A. Rigotti Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1732 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Covey, M. Krieger, W. Wang, M. Penman, and B. L. Trigatti Scavenger Receptor Class B Type I-Mediated Protection Against Atherosclerosis in LDL Receptor-Negative Mice Involves Its Expression in Bone Marrow-Derived Cells Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1589 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Desrumaux, P. A. Mak, W. A. Boisvert, D. Masson, D. Stupack, M. Jauhiainen, C. Ehnholm, and L. K. Curtiss Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells J. Lipid Res., August 1, 2003; 44(8): 1453 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van Eck, J. Twisk, M. Hoekstra, B. T. Van Rij, C. A. C. Van der Lans, I. S. T. Bos, J. K. Kruijt, F. Kuipers, and T. J. C. Van Berkel Differential Effects of Scavenger Receptor BI Deficiency on Lipid Metabolism in Cells of the Arterial Wall and in the Liver J. Biol. Chem., June 20, 2003; 278(26): 23699 - 23705. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rigotti, H. E. Miettinen, and M. Krieger The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues Endocr. Rev., June 1, 2003; 24(3): 357 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, X. Jiang, F. Yang, J. W. Gaubatz, L. Ma, M. J. Magera, X. Yang, P. B. Berger, W. Durante, H. J. Pownall, et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta -synthase and apolipoprotein E double knock-out mice with and without dietary perturbation Blood, May 15, 2003; 101(10): 3901 - 3907. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Imachi, K. Murao, W. Cao, S. Tada, T. Taminato, N. C.W. Wong, J. Takahara, and T. Ishida Expression of Human Scavenger Receptor B1 on and in Human Platelets Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 898 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Rikitake, K.-i. Hirata, T. Yamashita, K. Iwai, S. Kobayashi, H. Itoh, M. Ozaki, J. Ejiri, M. Shiomi, N. Inoue, et al. Expression of G2A, a Receptor for Lysophosphatidylcholine, by Macrophages in Murine, Rabbit, and Human Atherosclerotic Plaques Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2049 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsukamoto, K.-i. Hirano, S. Yamashita, N. Sakai, C. Ikegami, Z. Zhang, F. Matsuura, H. Hiraoka, A. Matsuyama, M. Ishigami, et al. Retarded Intracellular Lipid Transport Associated With Reduced Expression of Cdc42, a Member of Rho-GTPases, in Human Aged Skin Fibroblasts: A Possible Function of Cdc42 in Mediating Intracellular Lipid Transport Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1899 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, M. Febbraio, D. P. Hajjar, et al. A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions J. Biol. Chem., October 4, 2002; 277(41): 38517 - 38523. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marsche, A. Hammer, O. Oskolkova, K. F. Kozarsky, W. Sattler, and E. Malle Hypochlorite-modified High Density Lipoprotein, a High Affinity Ligand to Scavenger Receptor Class B, Type I, Impairs High Density Lipoprotein-dependent Selective Lipid Uptake and Reverse Cholesterol Transport J. Biol. Chem., August 23, 2002; 277(35): 32172 - 32179. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mardones, P. Strobel, S. Miranda, F. Leighton, V. Quinones, L. Amigo, J. Rozowski, M. Krieger, and A. Rigotti {alpha}-Tocopherol Metabolism Is Abnormal in Scavenger Receptor Class B Type I (SR-BI)-Deficient Mice J. Nutr., March 1, 2002; 132(3): 443 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Hullinger, R. L. Panek, X. Xu, and S. K. Karathanasis p21-activated Kinase-1 (PAK1) Inhibition of the Human Scavenger Receptor Class B, Type I Promoter in Macrophages Is Independent of PAK1 Kinase Activity, but Requires the GTPase-binding Domain J. Biol. Chem., December 7, 2001; 276(50): 46807 - 46814. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gillotte-Taylor, A. Boullier, J. L. Witztum, D. Steinberg, and O. Quehenberger Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein J. Lipid Res., September 1, 2001; 42(9): 1474 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lin, Z. H. Huang, and T. Mazzone Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE J. Lipid Res., July 1, 2001; 42(7): 1125 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Cai, R. J. Kirby, P. N. Howles, and D. Y. Hui Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine J. Lipid Res., June 1, 2001; 42(6): 902 - 909. [Abstract] [Full Text] |
||||
![]() |
M. Kapinsky, M. Torzewski, C. Buchler, C. Q. Duong, G. Rothe, and G. Schmitz Enzymatically Degraded LDL Preferentially Binds to CD14high CD16+ Monocytes and Induces Foam Cell Formation Mediated Only in Part by the Class B Scavenger-Receptor CD36 Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Husemann and S. C. Silverstein Expression of Scavenger Receptor Class B, Type I, by Astrocytes and Vascular Smooth Muscle Cells in Normal Adult Mouse and Human Brain and in Alzheimer's Disease Brain Am. J. Pathol., March 1, 2001; 158(3): 825 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumoto, K.-i. Hirano, S. Nozaki, A. Takamoto, M. Nishida, Y. Nakagawa-Toyama, M. Y. Janabi, T. Ohya, S. Yamashita, and Y. Matsuzawa Expression of Macrophage (M{phi}) Scavenger Receptor, CD36, in Cultured Human Aortic Smooth Muscle Cells in Association With Expression of Peroxisome Proliferator Activated Receptor-{gamma}, Which Regulates Gain of M{phi}-Like Phenotype In Vitro, and Its Implication in Atherogenesis Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1027 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gu, K. Kozarsky, and M. Krieger Scavenger Receptor Class B, Type I-mediated [3H]Cholesterol Efflux to High and Low Density Lipoproteins Is Dependent on Lipoprotein Binding to the Receptor J. Biol. Chem., September 22, 2000; 275(39): 29993 - 30001. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wang, D. L. Silver, P. Costet, and A. R. Tall Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1 J. Biol. Chem., October 13, 2000; 275(42): 33053 - 33058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Yancey, M. de la Llera-Moya, S. Swarnakar, P. Monzo, S. M. Klein, M. A. Connelly, W. J. Johnson, D. L. Williams, and G. H. Rothblat High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI J. Biol. Chem., November 17, 2000; 275(47): 36596 - 36604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Han, A. C. Nicholson, X. Zhou, J. Feng, A. M. Gotto Jr., and D. P. Hajjar Oxidized Low Density Lipoprotein Decreases Macrophage Expression of Scavenger Receptor B-I J. Biol. Chem., May 4, 2001; 276(19): 16567 - 16572. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ohgami, R. Nagai, A. Miyazaki, M. Ikemoto, H. Arai, S. Horiuchi, and H. Nakayama Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products J. Biol. Chem., April 13, 2001; 276(16): 13348 - 13355. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |